The Food and Drug Administration (FDA) and the Centers for Medicare & Medicaid Services (CMS) are looking into collaborating with state authorities regarding the regulation of artificial intelligence in healthcare. As AI technologies continue to advance and integrate into medical applications, federal health agencies are seeking ways to work alongside state governments to establish effective oversight and regulatory frameworks.